ARCHIVES

Jerome Yates Named VP For Research At ACS

This article is from The Cancer Letter archive.

Vol. 28 No. 06 | February 8, 2002

Download PDF Visit The Full Archive

Related Articles

How the Institute Fared In House Markup: Chart

July 18, 1997

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

November 8, 1991

Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting

August 29, 2003

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

March 25, 2011